Steven N. Goodman

American epidemiologist

Steven N Goodman

Citizenship| American
Education| AB, Harvard College, Biochemistry, Applied Math (1976)
Alma mater| Harvard University
New York University
Johns Hopkins School of Public Health;
Known for| "Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy, and 2: The Bayes Factor"
Awards| Spinoza Chair in Medicine (2016), National Academy of Medicine (2020)
Scientific career
Fields| Medical Research, Epidemiology, Statistics, Metascience
Thesis|  Evidence and Clinical Trials  (1989)
Doctoral advisor| Richard Royall
Other academic advisors| Curt Meinert

Steven N. Goodman (born 1954) is an American Professor of Epidemiology and Population Health and of Medicine at the Stanford School of Medicine.[1] He has extensively contributed to foundations of scientific and statistical inference within the biosciences, and in 1999 he coined the term "p-value fallacy".[2]

## Works

[edit]

He has made numerous contributions to the methods of clinical research, comparative effectiveness, meta analysis, and scientific inference,[3][4][5][6][7][8][9][10][11][12][13][14] in addition to works on scientific evidence.[15][16][17][18][19][20][21][22][23][24][25][26][27][28]

## References

[edit]

1. ^ "Steven Goodman".
2. ^ Sellke, Thomas; Bayarri, M. J; Berger, James O (February 2001). "Calibration of ρ Values for Testing Precise Null Hypotheses". The American Statistician. 55 (1): 62–71. doi:10.1198/000313001300339950. S2CID 396772.
3. ^ Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., Goodman, S. N. (2014). "Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change". Annals of Internal Medicine. 160 (4): 267–270. doi:10.7326/M13-2886. PMID 24727843. S2CID 9210956.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
4. ^ Basch, E., Aronson, N., Berg, A., Flum, D., Gabriel, S., Goodman, S. N., Helfand, M., Ioannidis, J. P., Lauer, M., Meltzer, D., Mittman, B., Newhouse, R., Normand, S., Schneeweiss, S., Slutsky, J., Tinetti, M., Yancy, C. (2012). "Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective". JAMA. 307 (15): 1636–1640. doi:10.1001/jama.2012.466. PMID 22511692.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
5. ^ Goodman, S. N. (2012). "Quasi-random reflections on randomized controlled trials and comparative effectiveness research". Clinical Trials. 9 (1): 22–26. doi:10.1177/1740774511433285. PMID 22334465. S2CID 22693531.
6. ^ Sox, H. C., Goodman, S. N. (2012). "The Methods of Comparative Effectiveness Research". Annual Review of Public Health. 33: 425–445. doi:10.1146/annurev-publhealth-031811-124610. PMID 22224891.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
7. ^ Goodman, S., Dickersin, K. (2011). "Metabias: A Challenge for Comparative Effectiveness Research". Annals of Internal Medicine. 155 (1): 61–2. doi:10.7326/0003-4819-155-1-201107050-00010. PMID 21727295. S2CID 43451703.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
8. ^ Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., Schwartz, J. S. (2009). "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change". Annals of Internal Medicine. 151 (3): 206–209. doi:10.7326/0003-4819-151-3-200908040-00126. PMID 19567619.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
9. ^ Goodman SN, Greenland S (2007). "Assessing the unreliability of the medical literature: A response to "Why most published research findings are false"". Archived from the original on 2012-04-06. `{{cite journal}}`: Cite journal requires `|journal=` (help)
10. ^ Goodman, S. N. (2002). "The mammography dilemma: A crisis for evidence-based medicine?". Annals of Internal Medicine. 137 (5): 363–365. doi:10.7326/0003-4819-137-5_part_1-200209030-00015. PMID 12204023. S2CID 40784168.
11. ^ Goodman, S. N., Zahurak, M. L., PIANTADOSI, S. (1995). "Some practical improvements in the continual reassessment method for phase I studies". Statistics in Medicine. 14 (11): 1149–1161. doi:10.1002/sim.4780141102. PMID 7667557.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
12. ^ Goodman, S. N., Berlin, J. A. (1994). "The Use of Predicted Confidence Intervals when Planning Experiments and the Misuse of Power when Interpreting Results". Annals of Internal Medicine. 121 (3): 200–206. doi:10.7326/0003-4819-121-3-199408010-00008. PMID 8017747. S2CID 53089940.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
13. ^ Goodman, S. N. (1989). "Meta-analysis and evidence". Controlled Clinical Trials. 10 (2): 188–204. doi:10.1016/0197-2456(89)90030-5. PMID 2666026.
14. ^ Goodman, S. N., Royall, R. (1988). "Evidence and scientific research". American Journal of Public Health. 78 (12): 1568–1574. doi:10.2105/ajph.78.12.1568. PMC 1349737. PMID 3189634.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
15. ^ Glass, T. A., Goodman, S. N., Hernán, M. A., Samet, J. M. (2013). "Causal inference in public health". Annual Review of Public Health. 34: 61–75. doi:10.1146/annurev-publhealth-031811-124606. PMC 4079266. PMID 23297653.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
16. ^ Faden, R. R., Kass, N. E., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics". Hastings Center Report. 43: S16-27. doi:10.1002/hast.134. PMID 23315888.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
17. ^ Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight". Hastings Center Report. 43: S4–S15. doi:10.1002/hast.133. PMID 23315895.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
18. ^ Mello, M. M., Goodman, S. N., Faden, R. R. (2012). "Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report". New England Journal of Medicine. 367 (10): 959–964. doi:10.1056/NEJMhle1207160. PMID 22913661. S2CID 36551817.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
19. ^ Goodman, S. (2011). "Confessions of a chagrined trialist". BMJ Quality & Safety. 20 (Suppl_1): i97–i98. doi:10.1136/bmjqs.2010.046623. PMC 3066790. PMID 21450783.
20. ^ Goodman, S. N. (2007). "Stopping at nothing? Some dilemmas of data monitoring in clinical trials". Annals of Internal Medicine. 146 (12): 882–887. doi:10.7326/0003-4819-146-12-200706190-00010. PMID 17577008. S2CID 21243453.
21. ^ Laine, C., Goodman, S. N., Griswold, M. E., Sox, H. C. (2007). "Reproducible research: Moving toward research the public can really trust". Annals of Internal Medicine. 146 (6): 450–453. doi:10.7326/0003-4819-146-6-200703200-00154. PMID 17339612. S2CID 1359523.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
22. ^ Goodman, S. N., Sladky, J. T. (2005). "A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain–Barre syndrome". Clinical Trials. 2 (4): 305–310. doi:10.1191/1740774505cn102oa. PMID 16281429. S2CID 22919090.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
23. ^ Goodman, S. N. (2001). "Of P-values and bayes: A modest proposal". Epidemiology. 12 (3): 295–297. doi:10.1097/00001648-200105000-00006. PMID 11337600. S2CID 41986475.
24. ^ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 1: The P value fallacy". Annals of Internal Medicine. 130 (12): 995–1004. doi:10.7326/0003-4819-130-12-199906150-00008. PMID 10383371. S2CID 7534212.
25. ^ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 2: The Bayes factor". Annals of Internal Medicine. 130 (12): 1005–1013. doi:10.7326/0003-4819-130-12-199906150-00019. PMID 10383350. S2CID 13186212.
26. ^ Goodman, S. N., Berlin, J., Fletcher, S. W., Fletcher, R. H. (1994). "Manuscript Quality before and after Peer Review and Editing at Annals of Internal Medicine". Annals of Internal Medicine. 121 (1): 11–21. doi:10.7326/0003-4819-121-1-199407010-00003. PMID 8198342. S2CID 5716602.`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
27. ^ Goodman, S. N. (1993). "P Values, Hypothesis Tests, and Likelihood: Implications for Epidemiology of a Neglected Historical Debate". American Journal of Epidemiology. 137 (5): 485–496. doi:10.1093/oxfordjournals.aje.a116700. PMID 8465801.
28. ^ Goodman, S. N. (1992). "A comment on replication, P-values and evidence". Statistics in Medicine. 11 (7): 875–879. doi:10.1002/sim.4780110705. PMID 1604067.

Authority control databases

International|

* VIAF
* WorldCat

National|

* United States
* Israel

Academics|

* MathSciNet

## External links

[edit]

* Esteller, Manel; Garcia-Foncillas, Jesus; Andion, Esther; Goodman, Steven N.; Hidalgo, Oscar F.; Vanaclocha, Vicente; Baylin, Stephen B.; Herman, James G. (2000). "Cancer research: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents". New England Journal of Medicine. 343 (19): 1350–1354. doi:10.1056/NEJM200011093431901. hdl:2445/176306. PMID 11070098. S2CID 40303322.